SCHEMBL7207048

SCHEMBL7207048

CSc1ccc(Br)c(C(=O)O)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.65
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
HSD17B10 Q99714 5/20 0.43
TSHR P16473 3/20 0.43
AKR1C3 P42330 3/20 0.41
AKR1C2 P52895 3/20 0.41
KMT2A Q03164 2/20 0.40
HTT P42858 1/20 0.39
DTYMK P23919 1/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
PTPN6 P29350 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
HPGD P15428 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA3 P07451 1/20 0.38
CA4 P22748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10274092 0.85 MCL1 (0.59) MCL1LCKFYNHSD17B10TSHR
SCHEMBL2894468 0.84 DTYMK (0.53) MCL1LCKFYNHSD17B10TSHR
SCHEMBL11723811 0.82 MCL1 (0.71) MCL1HSD17B10TSHRAKR1C3AKR1C2
SCHEMBL26664565 0.80 MCL1 (0.46) MCL1HSD17B10TSHRKMT2AHTT
SCHEMBL2845642 0.78 MCL1 (0.67) MCL1HSD17B10TSHRAKR1C3AKR1C2
SCHEMBL3187695 0.78 MCL1 (1.00) MCL1LCKHSD17B10KMT2AHTT
SCHEMBL10373746 0.78 MCL1 (0.61) MCL1LCKFYNTSHRKMT2A
SCHEMBL11214673 0.77 MCL1 (0.65) MCL1HSD17B10TSHRAKR1C3AKR1C2
SCHEMBL1285810 0.77 MCL1 (0.65) MCL1HSD17B10TSHRKMT2AHTT
SCHEMBL2823587 0.77 MCL1 (0.65) MCL1HSD17B10TSHRAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1188121-C Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-09 CN disclosed
EP-0705100-B1 THERAPEUTIC SUBSTITUTED GUANIDINES CENES LTD (GB) 2003-07-30 EP disclosed
US-6156741-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-12-05 US disclosed
US-6153604-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-11-28 US disclosed
US-6147063-A NEUROTOXICITY CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-11-14 US disclosed
CN-1126434-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE INC (US) 1996-07-10 CN disclosed